Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Vaecgene Biotech GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Clinical Diagnostics, Proteomics, Drug Development, ImmuneTherapy, Infectious Diseases, OncologyVaecgene focuses on the research and development of novel therapeuticsand in vitro diagnostics. Core competence and proprietary technology arethe development of viral vectors that helped Vaecgene to establish a broadportfolio including individual drugs for immunological treatment of tumorsand infectious diseases. Recently, Vaecgene has developed a new intelligenttechnology, AMIDA, for functional proteomics for fast and efficient identificationand validation of tumor markers for early detection of cancer. In addition,the company offers services related to Epstein-Barr-Virus.The company has also extensive experience in monitoring and quantitatingthe immune competence in patients and non- human primates.Contact:Dr. Reinhard ZeidlerMarchioninistr. 25D-81377 MünchenPhone: +49 (0) 89 70992-96Fax: +49 (0) 89 70992-25E-Mail: info@vaecgene.deInternet: www.vaecgene.devasopharm GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSvasopharm is a pharmaceutical company dedicated to the discovery anddevelopment of novel therapeutics for the treatment of cerebro- and cardiovasculardiseases and their consequences. The company is focused on thedevelopment of therapeutics which permits steering the bioavailability ofbiological NO, covering the entire NO/cGMP signal cascade and its functionalcounterpart NOX. vasopharm’s drug candidate VAS203 represents acompletely new class of NOS modulators targeting cerebral vessels andcerebral tissue, thus preventing life threatening rises in intracranial pressureafter a traumatic brain injury. www.vasopharm.comContact:Christian WanderseeFriedrich-Bergius-Ring 15D-97076 WürzburgPhone: +49 (0) 931 359099-0Fax: +49 (0) 931 359099-12E-Mail: office@vasopharm.comInternet: www.vasopharm.comvermicon AGBIOTECH AGRO, FOOD, ENVIRONMENTvermicon AG offers solutions for microbiology. The company develops andmarkets products and services for the detection and analysis of microorganisms.Additionally the company offers microbiological consulting.Its approach is new and non-conventional. Our portfolio comprises: Theproducts - our detection systems for industrial and private customers. Theservices - extensive analyses for microbiology. Microbiological consulting –the unique link between microbiology and consulting. The power of thetechnology portfolio combined with a strong and innovative team consistingof microbiologists and chemists allows us to explore completely new andexciting ways.Contact:Barbara RoderusEmmy-Noether-Str. 2D-80992 MünchenPhone: +49 (0) 89 15882-0Fax: +49 (0) 89 15882-100E-Mail: info@vermicon.comInternet: www.vermicon.com117